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Background: Si-Wu-Tang (SWT), a Traditional Chinese Medicine (TCM) formula, is widely used for the treatment of
gynopathies diseases such as menstrual discomfort, climacteric syndrome, dysmenorrhea, and other estrogen-
related diseases. Recent studies have shown that SWT can treat primary dysmenorrhea, have anti-pruritic anti-
inflammatory effects, and protect against radiation-induced bone marrow damage in an animal model. It has been
reported that anti-inflammatory and anti-oxidant agents have the potential to treat osteoporosis by increasing bone
formation and/or suppressing bone resorption. However, the effect of SWT on bone cell function has not yet been
reported.
Methods: Alkaline phosphatase (ALP), bone morphogenetic proteins (BMP)-2, and osteopontin (OPN) mRNA
expression was analyzed by qPCR. The mechanism of action of SWT extract was investigated using western
blotting. The in vivo anti-osteoporotic effect of SWT extract was assessed in ovariectomized mice.
Results: Here, we report that SWT increases ALP, BMP-2, and OPN expression as well as bone mineralization. In
addition, we show that the PI3K, Akt, and NF-κB signaling pathways may be involved in the SWT-mediated increase
in gene expression and bone mineralization. Notably, treatment of mice with SWT extract prevented bone loss
induced by ovariectomy in vivo.
Conclusion: SWT may be used to stimulate bone formation for the treatment of osteoporosis.
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Bone is a mineralized tissue composed of several cell
types, which undergoes a continuous renewal and repair
process called “bone remodeling”. Bone remodeling is
accomplished by bone-forming osteoblasts and bone-
resorbing osteoclasts that reside in the bone. The de-
velopment and differentiation of these 2 cell types are
tightly regulated by a number of endogenous substances
such as hormones, growth factors, and cytokines [1].
These factors are secreted through the endocrine, para-
crine/autocrine, and neurocrine systems, and modulate
the balance between bone-forming and bone-resorbing* Correspondence: chtang@mail.cmu.edu.tw
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reproduction in any medium, provided the orcells in the marrow microenvironment. Osteoporosis re-
sults when bone resorption and bone formation are
imbalanced and excess bone breakdown exceeds bone
building [2]. Bone resorption inhibitors, e.g., bispho-
sphonates, calcitonin, and estrogen, were designed as
therapeutic targets to treat osteoporosis [3]. However,
the efficiency of these drugs in improving bone mass
is very small, certainly no more than 2% per year [3].
Therefore, teriparatide, an anabolic agent, which stimu-
lates bone formation and corrects characteristic changes
in the trabecular microarchitecture in established osteo-
porosis, is a new approach to treat osteoporosis [4,5].
Bone remodeling is regulated through a balance of
bone-forming and bone-resorbing cell activities that to-
gether maintain bone mass and mineral homeostasis.
New bone formation is mainly controlled by osteoblasts;
therefore, agents that act to either increase proliferation. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ation of osteoblasts can enhance bone formation [5-7].
The biological mechanism of osteoporosis is still un-
clear. However, it is likely related to decreased availa-
bility or effects of bone growth factors such as bone
morphogenetic proteins (BMPs) [8]. BMPs were first dis-
covered as a result of their capacity to induce ectopic
bone formation in rodents, and the protein structure of
BMPs are similar to the transforming growth factor-β
superfamily [9]. BMPs are secreted proteins, which play
crucial roles in bone formation and bone cell differenti-
ation through stimulation of alkaline phosphatase (ALP)
activity as well as synthesis of proteoglycan, collagen,
and osteopontin (OPN) [10]. A previous study showed
linkage of osteoporosis to specific polymorphisms in the
BMP-2, ALP, and OPN genes, revealing that they are
osteoporosis-associated genes [11].
Si-Wu-Tang (SWT), a Traditional Chinese Medicine
(TCM) formula, is comprised of a combination of 4 herbs;
Paeoniae, Angelicae, Chuanxiong, and Rehmanniae, and is
widely used for the treatment of women’s diseases such as
cutaneous pruritus and chronic inflammation, and other
diseases. Modern pharmacological studies have shown that
SWT extract has anti-pruritic [12] and anti-inflammatory
effects [12], and protects against radiation-induced bone
marrow damage in an animal model [13,14]. Previous stud-
ies have shown that anti-inflammatory and anti-oxidant
agents have the potential to treat osteoporosis by increas-
ing bone formation and/or suppressing bone resorption
[15,16]. However, the effect of SWT on bone cell function
has not yet been reported. In the current study, we report
that SWT extract increases ALP, BMP-2, and OPN expres-
sion and bone mineralization. Furthermore, we show that
the phosphatidylinositol 3-kinase (PI3K), Akt, and NF-κB
signaling pathways are involved in the SWT-mediated in-
crease in gene expression and bone mineralization. Finally,
treatment of mice with SWT extract prevented bone loss
induced by ovariectomy in vivo. Our data, therefore, sug-
gest that SWT may be used to stimulate bone formation
for the treatment of osteoporosis.
Methods
SWT extract and materials
SWT extract was kindly provided by Timing Pharmaceut-
ical Company (New Taipei City, Taiwan). The extraction
and isolation of SWT were performed as previously de-
scribed [17]. Rabbit polyclonal antibodies for BMP-2, OPN,
p-p85 (Tyr458), p85, p-Akt (Ser473), Akt, p-p65 (Ser536), and
p65 were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). The osteopontin BMP-2 ELISA kit was
purchased from Biosource Technology (Nivelles, Belgium).
The C-terminal telopeptides of type-I collagen ELISA
kit was obtained from Cross Laps (Herlev, Denmark).
p85 and Akt siRNAs were purchased from Santa CruzBiotechnology. All other reagents were obtained from
Sigma-Aldrich (St. Louis, MO, USA).
Cell culture
The murine osteoblast cell line MC3T3-E1 was purchased
from American Type Culture Collection (ATCC; Rockville,
MD, USA). Cells were cultured in 5% CO2 with α-MEM
supplemented with 20 mM HEPES and 10% heat-
inactivated fetal calf serum, 2 mM glutamine, penicillin
(100 units/mL), and streptomycin (100 μg/mL).
Measurement of mineralized nodule formation
Levels of mineralized nodule formation were evaluated
as previously described [18,19]. Briefly, osteoblasts were
cultured in medium containing vitamin C (50 μg/mL)
and β-glycerophosphate (10 mM) for 2 wks, and the
medium was changed every 3 d. After incubation with
SWT extract for 12 d, cells were washed twice with
20 mM Tris-buffered saline containing 0.15 M NaCl
(pH 7.4), fixed in ice-cold 75% (v/v) ethanol for 30 min,
and air-dried. Calcium deposition was determined using
alizarin red-S staining. Briefly, ethanol-fixed cells and
matrix were stained for 1 h with 40 mM alizarin red-S
(pH 4.2) and rinsed extensively with water. The bound
stain was eluted with 10% (w/v) cetylpyridinium chlor-
ide, and alizarin red-S in the samples was quantified by
measuring absorbance at 550 nm and comparing to
a standard curve. One mole of alizarin red-S selectively
binds approximately 2 moles of calcium.
Quantitative real time PCR
Total RNA was extracted from osteoblasts using a TRIzol
kit (MDBio Inc., Taipei, Taiwan). Reverse transcription was
performed using 2 μg of total RNA and oligo(dT) primers
[20,21]. Quantitative real-time PCR (qPCR) was carried
out using TaqMan® One-Step PCR Master Mix (Applied
Biosystems, Carlsbad, CA, USA). cDNA (100 ng) was
added to a 25-μL reaction containing sequence-specific
primers and Taqman® probes. All target gene primers and
probes were purchased commercially, including β-actin as
an internal control (Applied Biosystems). qPCR assays
were carried out in triplicate on a StepOnePlus sequence
detection system (Applied Biosystems). The cycling condi-
tions were as follows: 10-min polymerase activation at
95°C followed by 40 cycles of 95°C for 15 s and 60°C for
60 s. The threshold was set above the non-template con-
trol background and within the linear phase of target gene
amplification to calculate the cycle number at which the
transcript was detected (denoted CT).
Cell viability
Cell viability was determined by 3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazoliumbromide (MTT) assay. After
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washed with PBS. MTT (0.5 mg/ml) was then added to
each well and the mixture was incubated for 2 h at 37°C.
Culture medium was then replaced with equal volume of
DMSO to dissolve formazan crystals. After shaking at
room temperature for 10 min, absorbance of each well
was determined at 550 nm using a microplate reader (Bio-
Tek, Winooski, VT).
Western blot analysis
Cell lysates were prepared as described previously [22].
Proteins were resolved by SDS-PAGE and transferred
to Immobilon polyvinyldifluoride membranes (Millipore,Figure 1 SWT extract increases bone mineralization in cultured osteo
2 wks in medium containing vitamin C (50 μg/mL) and β-glycerophosphat
the end of the experiment, cultures were fixed in 75% ethanol, and minera
bound stain was eluted with a solution of 10% cetylpyridinium chloride an
with SWT extract for 72 h, and ALP was measured with an ALP activity assa
BMP-2, and OPN mRNA expression was measured by qPCR. (D) Cells were i
(negative control) neutralizing antibodies. Mineralized nodule formation wa
extract (150 μg/mL) plus BMP-2, OPN, or IgG (negative control) neutralizing
kit. (F) Cells were incubated with SWT extract, the cell viability was examin
compared to the control group; #, p < 0.05 compared to the SWT extract-trBillerica, MA, USA). The blots were blocked with 4% bo-
vine serum albumin for 1 h at room temperature, and then
probed with rabbit anti-human antibodies against p85,
p-p85, p-Akt, Akt, p65, or p-p65 (1:1000) for 1 h at room
temperature. After 3 washes, the blots were incubated
with peroxidase-conjugated donkey anti-rabbit secondary
antibody (1:1000) for 1 h at room temperature. The blots
were visualized by enhanced chemiluminescence using X-
OMAT LS film (Eastman Kodak, Rochester, NY).
Ovariectomy-induced osteoporosis
Female ICR mice (4 wks old; 22–28 g) were used for
this study. Mice were ovariectomized bilaterally underblasts. (A) Osteoblasts were seeded in 24-well plates and cultured for
e (10 mM). The cells were concomitantly treated with SWT extract. At
lized nodule formation was assessed by alizarin red-S staining. The
d quantified using a microtiter plate reader. (B) Cells were incubated
y kit. (C) Cells were incubated with SWT extract for 24 h, and ALP,
ncubated with SWT extract (150 μg/mL) plus BMP-2, OPN, or IgG
s assessed by alizarin red-S staining. (E) Cells were incubated with SWT
antibodies for 72 h, and ALP was measured with an ALP activity assay
ed by MTT assay. Results are expressed as mean ± SEM *, p < 0.05
eated group.
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trol mice were sham-operated (Sham) for comparison.
Bone mineral density and bone mineral content were
measured after oral administration of various concen-
trations of SWT extracts every 2 d for 4 wks. Total body
bone mineral density and bone mineral content were
determined by a dual-energy X-ray absorptiometer (DEXA;
XR-26; Norland, Fort Atkinson, WI) using a mode for
small subjects as described previously [19,23]. All pro-
tocols complied with institutional guidelines and were
approved by the Animal Care Committee of China
Medical University.Statistical analysis
Statistical analysis was performed using Prism 4.01 soft-
ware (GraphPad Software Inc., San Diego, CA, USA).
The values given are means ± standard errors of the
mean (SEM). Statistical analyses between 2 samples were
performed using the Student’s t-test. Statistical compari-
sons of more than 2 groups were performed using 1-way
analysis of variance with Bonferroni’s post-hoc test. In all
cases, p < 0.05 was considered significant.Figure 2 Involvement of PI3K in SWT extract-induced bone mineraliza
cultured for 2 wks in medium containing vitamin C (50 μg/mL) and β-glyc
extract (150 μg/mL) plus Ly294002 or wortmannin. Mineralized nodule form
with SWT extract (150 μg/mL) plus Ly294002 or wortmannin for 72 h, and
pretreated with Ly294002 and wortmannin for 30 min or transfected with
and ALP, BMP-2, and OPN mRNA expression was measured by qPCR. (D) Ce
p-p85 phosphorylation was examined by western blotting. *, p < 0.05 comp
extract-treated group.Results
SWT extract increases bone mineralization by osteoblasts
In this study, we investigated the role of SWT in osteo-
blast differentiation. The formation of mineralized nodules
is a marker of osteoblast maturation. Alizarin red-S stain-
ing showed that mineralized nodules formed when osteo-
blasts were cultured for 2 wks in medium containing
vitamin C (50 μg/mL) and β-glycerophosphate (10 mM),
and this increased in a concentration-dependent manner
with the addition of SWT (Figure 1A). Differentiated oste-
oblasts exhibit elevated ALP activity, which correlates with
high levels of enzyme expression [18,24]. Therefore, we
assessed the effects of SWT on osteoblast ALP activity,
and our results showed that treatment with SWT extract
for 72 h significantly increased ALP activity (Figure 1B). It
is a general view that BMP-2, ALP, and OPN have crucial
roles in osteoblast differentiation. We tested whether
SWT extract mediates its effects on osteoblast differenti-
ation by regulation of the expression of BMP-2, ALP, and
OPN. Treatment of cells with SWT extract increased
the mRNA expression of ALP, BMP-2, and OPN in a
concentration-dependent manner (Figure 1C). To investi-
gate whether the induction of BMP-2 and OPN expressiontion in osteoblasts. (A) Cells were seeded in 24-well plates and
erophosphate (10 mM). The cells were concomitantly treated with SWT
ation was assessed by alizarin red-S staining. (B) Cells were incubated
ALP was measured with an ALP activity assay kit. (C) Cells were
p85 siRNA for 24 h followed by stimulation with SWT extract for 24 h,
lls were treated with SWT extract for the indicated time intervals, and
ared to the control group; #, p < 0.05 compared to the SWT
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assessed the inhibitory effects of a neutralizing antibody
against BMP-2 and OPN. Our data showed that SWT-
induced bone nodule formation and ALP mRNA ex-
pression was significantly decreased after treatment with
the neutralizing antibody (Figure 1D and E). However,
SWT did not affect cell viability in osteoblasts (Figure 1F).
These results demonstrated that SWT extract induced dif-
ferentiation of osteoblasts by upregulating BMP-2, ALP,
and OPN expression.
SWT extract increases bone nodule formation through
the PI3K/Akt pathway
It has been reported that PI3K and Akt play an important
role in bone formation [25,26]. We next examined
whether these signaling pathways are involved in SWT
extract-induced bone mineralization. The osteoblasts were
pretreated with a PI3K inhibitor (Ly294002 and wortman-
nin) or an Akt inhibitor for 30 min and then incubated
with SWT extract for 24 h. Pretreatment of cells with
these pathway inhibitors reduced SWT extract-induced
bone mineralization (Figures 2A and 3A). The inhibitors
also decreased ALP activity that was upregulated by SWT
extract (Figures 2B and 3B). Furthermore, pretreatment
with the inhibitors or transfection of cells with p85 andFigure 3 Involvement of Akt in SWT extract-induced bone mineraliza
cultured for 2 wks in medium containing vitamin C (50 μg/mL) and β-glyc
extract (150 μg/mL) plus Akt inhibitor. Mineralized nodule formation was a
extract (150 μg/mL) plus Akt inhibitor for 72 h, and ALP was measured wit
for 30 min or transfected with Akt siRNA for 24 h followed by stimulation w
was measured by qPCR. (D) Cells were treated with SWT extract for the ind
blotting. *, p < 0.05 compared to the control group; #, p < 0.05 compared tAkt siRNA blocked SWT extract-induced ALP, BMP-2,
and OPN mRNA expression (Figures 2C and 3C). Next,
we directly examined p85 and Akt activation after SWT
extract treatment. Incubation of cells with SWT extract
induced p85 and Akt phosphorylation (Figures 2D and
3D). Therefore, these results indicate that the PI3K and
Akt pathways are involved in SWT extract-induced bone
formation in osteoblasts.
SWT extract increases bone nodule formation through
the NF-κB pathway
As mentioned above, NF-κB activation is necessary for
bone formation [27,28]. We next pretreated osteoblasts
with NF-κB inhibitors (PDTC and TPCK) to determine
whether NF-κB activation is involved in SWT extract-
induced bone mineralization. The results showed that
pretreatment of osteoblasts with PDTC or TPCK inhib-
ited SWT extract-induced bone nodule formation; ALP
activity; and ALP, BMP-2, and OPN mRNA expression
(Figure 4A–C). NF-κB activation depends on phosphor-
ylation of the NF-κB p65 subunit [29]. Our results indi-
cate that SWT extract increased p65 phosphorylation in
osteoblasts (Figure 4D), showing that NF-κB activation
is crucial for SWT extract-induced expression of ALP,
BMP-2, and OPN, as well as bone nodule formation.tion in osteoblasts. (A) Cells were seeded in 24-well plates and
erophosphate (10 mM). The cells were concomitantly treated with SWT
ssessed by alizarin red-S staining. (B) Cells were incubated with SWT
h an ALP activity assay kit. (C) Cells were pretreated with Akt inhibitor
ith SWT extract for 24 h, and ALP, BMP-2, and OPN mRNA expression
icated time intervals, and p-Akt expression was examined by western
o the SWT extract-treated group.
Figure 4 Involvement of NF-κB in SWT extract-induced bone mineralization in osteoblasts. (A) Cells were seeded in 24-well plates and
cultured for 2 wks in medium containing vitamin C (50 μg/mL) and β-glycerophosphate (10 mM). The cells were concomitantly treated with SWT
extract (150 μg/mL) plus PDTC or TPCK. Mineralized nodule formation was assessed by alizarin red-S staining. (B) Cells were incubated with SWT
extract (150 μg/mL) plus PDTC or TPCK for 72 h, and ALP was measured with an ALP activity assay kit. (C) Cells were pretreated with PDTC or
TPCK for 30 min followed by stimulation with SWT extract for 24 h, and ALP, BMP-2, and OPN mRNA expression was measured by qPCR. (D) Cells
were treated with SWT extract for the indicated time intervals, and p-p65 phosphorylation was examined by western blotting. *, p < 0.05
compared to the control group; #, p < 0.05 compared to the SWT extract-treated group.
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mice
To assess the effects of SWT extract on bone loss, an
osteoporosis model was used, with female ovariecto-
mized mice. As expected, ovariectomized mice displayed
decreased total body bone mineral density and bone
mineral content (Figure 5A and B). However, treatment
with SWT extract for 4 wks reversed the loss in bone
mineral density and bone mineral content in a dose-
dependent manner (Figure 5A and B). Blood ALP concen-
tration is correlated with osteoblastic activity [30], and we
found that SWT extract inhibited the decrease in serum
ALP activity induced by ovariectomy (Figure 5C). SWT ex-
tract also increased the levels of BMP-2 and OPN, markers
of bone formation, and reduced the level of C-terminal tel-
opeptides of type I collagen, a marker of bone resorption
(Figure 5D–F). These findings open a new avenue for
SWT extract in the prevention of bone loss in vivo.
Discussion
Si-Wu-Tang, a TCM formula, is widely used in traditional
medicine for various therapeutics, including women’s
diseases, chronic inflammation, and other diseases because
of its anti-pruritic and anti-inflammatory effects [12]. In
this study, we showed that SWT extract induced bonemineralization in cultured osteoblasts. In addition, we
found that SWT extract increased the expression levels of
ALP, BMP-2, and OPN, which requires the activation
of PI3K, Akt, and NF-κB signaling pathways. SWT is com-
prised of a combination of 4 herbs; Paeoniae, Angelicae,
Chuanxiong, and Rehmanniae. On the other hand, the
major bioactive components in these 4 herbs include phe-
nolics, phthalides, alkaloids, terpene glycosides, and iridoid
glycosides. In the current study, we used SWT extract to
examine the role SWT in bone formation. However, we
did not extract and examine the role of single compound
in SWT. Therefore, the next step is to disclose which
compound is most important in SWT extract.
Bone is a complex tissue composed of several cell types
that are continuously undergoing a process of renewal and
repair [31]. Osteoporosis results from an imbalance be-
tween bone resorption and bone formation, where bone
breakdown overrides bone formation [31]. We took ad-
vantage of the ovariectomized mouse model to examine
the anti-osteoporotic effects of SWT extract. The results
showed that ovariectomized mice had reduced total body
bone mineral density and bone mineral content, and this
was reversed by treatment with SWT extract. SWT extract
also increased serum levels of the osteogenic markers
ALP, BMP-2, and OPN. Therefore, SWT is a novel bone
Figure 5 Inhibition of ovariectomy-induced decrease in bone mineral density and bone mineral content by SWT extract. (A) Female ICR
mice were given a sham operation or were ovariectomized. Mice that underwent ovariectomy were treated with the indicated concentrations of
SWT extract by oral feeding. Total body bone mineral density (A), bone mineral content (B), serum ALP activity (C), serum BMP-2 (D), serum OPN
(E), and serum C-terminal telopeptides of type I collagen (F), were determined 4 wks after surgery. Data are presented as mean ± SEM (n = 8–10
mice/group). *, p < 0.05 compared to sham; #, p < 0.05 compared to the ovariectomized group.
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in vivo.
The molecular mechanisms underlying osteoporosis are
not yet entirely clear. However, they are likely correlated
with decreased availability or activity of bone growth factors,
including ALP, BMP-2, and OPN. These 3 factors play im-
portant roles in the process of bone formation and remodel-
ing [23], and it has been well discussed that stimulation of
osteoblast cell differentiation is characterized mainly by in-
creased expression of ALP, BMP-2, and OPN [32]. In this
study, we found that SWT extract increased ALP, BMP-2,
and OPN expression and enhanced bone mineralization.
Therefore, SWT extract mediates bone formation by upreg-
ulating the expression of ALP, BMP-2, and OPN.Previous studies have reported that PI3K and Akt play
important roles in bone formation [25,26]. Phosphoryl-
ation of the p85 subunit is required for activation of the
p110 catalytic subunit of PI3K [33]. Here, we showed that
SWT extract induced PI3K and Akt phosphorylation, and
that pretreatment with inhibitors of these signal proteins
antagonized the SWT extract-mediated potentiation of
bone mineralization, revealing that PI3K and Akt activa-
tion play crucial roles in SWT extract-induced bone for-
mation by osteoblasts. Moreover, inhibitors and siRNA of
PI3K and Akt reduced SWT extract-dependent enhance-
ment of ALP, BMP-2, and OPN expression. These results
suggest that activation of the PI3K and Akt pathways are
required for increased ALP, BMP-2, and OPN expression
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reported that p38 is involved in the regulation of ALP ex-
pression during the differentiation of osteoblastic cells
[34]; similarly ERK1/2 is important for the proliferation
and differentiation of osteoblasts [35]. JNK is involved in
osteoblast formation [36]. However, we did not examine
the role of MAPKs (p38, JNK, and ERK) in SWT extract-
mediated bone formation in current study. Whether
MAPKs are involved in SWT extract-induced bone forma-
tion needs further examination.
NF-κB has been shown to control osteoblast function
in bone [37]. The results of our study indicate that NF-
κB activation contributes to SWT extract-induced bone
mineralization and ALP, BMP-2, and OPN expression in
cultured osteoblasts, and that inhibitors of the NF-κB
signaling pathway, including PDTC or TPCK, inhibited
SWT extract-induced bone mineralization and the ex-
pression of ALP, BMP-2, and OPN. Phosphorylation at
Ser536 of p65 is crucial for p65 transactivation [38]. The
results of this study showed that SWT extract increased
the phosphorylation of p65. Taken together, these results
suggest that NF-κB activation is required for SWT
extract-induced bone formation in cultured osteoblasts.
Conclusion
Our present study indicated that SWT extract induces
osteoblast differentiation and maturation. SWT extract
also increased ALP, BMP-2, and OPN expression, and
bone mineralization. SWT extract-mediated bone forma-
tion and the expression of ALP, BMP-2, and OPN were
mediated through PI3K, Akt, and NF-κB signaling path-
ways. Furthermore, SWT extract reversed in vivo bone
loss induced by ovariectomy. In conclusion, SWT may
be beneficial in stimulating bone formation for the treat-
ment of osteoporotic diseases.
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